9.03k followers • 19 symbols Watchlist by Motif Investing
Investors with bigger risk appetites in search of higher returns could drum up interest in small-cap growth companies.
RBC Bearings Incorporated
SPS Commerce, Inc.
ExlService Holdings, Inc.
USANA Health Sciences, Inc.
U.S. Physical Therapy, Inc.
Hollysys Automation Technologies Ltd.
BJ's Restaurants, Inc.
Shoe Carnival, Inc.
Hibbett Sports, Inc.
Use the DuPont technique to pick solid profit-generating stocks.
The direction of the NZD/USD on Friday is likely to be determined by trader reaction to the minor 50% level at .6483.
USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter results will be released after the close of market Tuesday, July 21, 2020. Shortly following the issuance of the Company’s earnings release, the Company will post a "Management Commentary, Results and Outlook" document on the Company’s website (http://ir.usana.com) under the "Investor Relations" section of the site. The following morning at 11:00 a.m. Eastern Time, USANA will hold a conference call to discuss this announcement with analysts and institutional investors.
Individual comfort varies from person to person, and the year-long partnership resulted in the development of new and improved software solutions that can accurately predict an individual’s personalized comfort and wellness. The partnership moved beyond thermal comfort predictions to include the effects of moisture on human comfort.
The direction of the NZD/USD the rest of the session on Friday is likely to be determined by trader reaction to the pivot at .6483.
Progress towards a COVID-19 vaccine and positive EU and U.S stats provided support early on. U.S Nonfarm payrolls and jobless claims are in focus later.
There’s plenty to consider as we enter the 3rd quarter. Brexit, a labor market recovery, possible trade wars, and Trump are all there to influence…
Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International
RBC Bearings Incorporated (Nasdaq: ROLL), a leading international manufacturer of highly engineered precision bearings and components for the industrial, aerospace and defense industries, today announced the nomination of Dolores J. Ennico to stand for election to its Board of Directors at the 2020 stockholders meeting to be held on September 9, 2020.
Luminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life Science Research Partners, achieving a major milestone in the company's strategy to extend its xMAP Technology with new functionality to facilitate new applications. Initially intended for research use only, the new system can double the multiplex capabilities of the xMAP platform, enabling partners and customers to explore new applications. Included in these applications is the unique ability to use a dual-reporter to simultaneously detect multiple COVID-19 antibodies in a single serology test.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]
Perficient today announced that it has become a Google Cloud Premier Partner, the highest status a Google Cloud partner can achieve.
Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.
In New Zealand, business confidence continues to improve as the economy returns to normal but still points to a recession according to an ANZ Survey.
It’s a busy day ahead, with economic data, talk of stimulus, geopolitics, and COVID-19 updates to provide the majors with direction.
Luminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for its xMAP® SARS-CoV-2 Multi-Antigen IgG assay. The assay was developed to provide additional capacity to detect antibodies in patients who may have been exposed to or infected by SARS-CoV-2. It delivers excellent results for up to 96 samples in under three hours and is designed to be run on all xMAP® platforms, with more than 17,000 systems sold globally, and 65+ Luminex global partners offering 1,300+ kits and custom assay solutions.
The RBNZ said it expects the decline in annual GDP this year to be the largest in at least 160 years.